Microvention, a wholly owned subsidiary of Terumo Corporation, is celebrating a decade of legacy innovation commemorating the anniversary of its Sofia and Sofia Flow Plus aspiration catheters, having performed more than half a million worldwide procedures across 170 countries, and with 30-plus articles published globally since it was first introduced 10 years ago.
This announcement was made at the ongoing Society of Vascular and Interventional Neurology (SVIN) annual meeting (16–18 November, Miami, USA), where Microvention is exhibiting in booth number 304.
In a press release Microvention claims that, from access to revascularisation, it now offers a fully integrated and streamlined portfolio of stroke solutions, including Sofia and Sofia Flow Plus, as well as the Eric retrieval device, Bobby balloon guide catheter, Wedge microcatheter, Headway microcatheters and Traxcess guidewires.
Microvention’s Sofia aspiration catheter is designed for tracking to the occlusion site and the aspiration of thrombus. Its “exceptionally” soft distal segment allows for excellent navigability and trackability through tortuous anatomy, enabling Sofia to reliably reach the occlusion site, according to the company. In addition, the device’s hybrid braid coil design provides enhanced control while its coil reinforcement enables “lumen integrity, flexibility and excellent shape retention”.
“Ten years ago, Microvention set the standard and re-envisioned catheter innovation through the development of Sofia catheters,” said Carsten Schroeder, president and chief executive officer, Microvention. “In this developmental milestone, we committed to meaningful advancements in stroke innovations to help improve patient lives around the world, and we will continue on this path with current and future investments.
“We are thankful for our remarkable partnerships with many physicians around the world where we work side by side to identify the evolving needs in patient care, and then transform those insights into cutting-edge technologies. Every new technology developed is inspired by the breakthrough that came before, now evidenced with Microvention’s fully integrated comprehensive portfolio of stroke solutions.”